A 70-year-old man presented with abdominal pain. Enhanced CT revealed a hypodense mass with peripheral enhancement in the pancreatic body (Picture 1). Endoscopic ultrasonography confirmed a well-defined hypoechoic mass measuring 20 mm in size (Picture 2). Endoscopic retrograde pancreatography showed a smooth narrowing of the pancreatic duct with displacement (Picture 3). Surgical resection was performed. The resected specimen measured 20×18 mm in size with a thick fibroid capsule. The histopathological results confirmed it to be undifferentiated carcinoma, with osteoclast-like giant cells (UCOGC) and no vascular invasion (Picture 4). There had been no further recurrence for over five years following surgery. UCOGC is a rare pancreatic malignancy that has been reported to have a more favorable prognosis than pancreatic ductal adenocarcinoma (1). The good outcome in such patients might be attributable to following factors. The presence of osteoclast-like giant cells has been associated with
Picture 4.
an improved prognosis (2) . In addition, the small tumor size and encapsulation may increase the survival period for such cases.
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